首站-论文投稿智能助手
典型文献
Enzyme-Linked Immunosorbent Assay for Detecting Syphilis Dry Blood Spot Samples
文献摘要:
Objective:To explore the feasibility of enzyme-linked immunosorbent assay(ELISA)in detecting syphilis dry blood spots.Methods:Based on dry blood spot samples,laboratory linear dial,laboratory basic dial,laboratory interference dial,and laboratory precision dial were constructed.The linear range,sensitivity,specificity,precision and other performances of ELISA for detecting syphilis dry blood spot samples were comprehensively evaluated,and the stability of dry blood spot samples at 37℃was detected.In addition,112 suspected syphilis antibody-positive plasma samples were selected as the control,and dry blood spot samples were prepared accordingly.The clinical sensitivity,clinical specificity,positive predictive value and negative predictive value of dry blood spot samples and plasma samples in ELISA for syphilis detection were compared,and the consistency and correlation between the two samples were analyzed by the Kappa consistency test and Spearman rank correlation analysis.Results:The results of the linear analysis showed that the serial dilution of dry blood spot samples in ELISA for syphilis antibody ranged from 23 to 27,and there was a good linear range[R2=0.9862(P<0.05)].Sensitivity and specificity analysis showed that the positive coincidence rate and negative coincidence rate of the two detection methods were 100%(15/15).The results of the interference dial test showed that ELISA based on dry blood spot samples could accurately detect 6 syphilis antibody samples from 18 samples,and the detection accuracy rate was 100.00%(6/6).The results of the precision test showed that the RSD of syphilis antibody detection in dry blood spot samples with different dilution times(23,25 and 27)was 0.24%to 3.87%between spots,0.06%to 4.07%between batches and 0.49%to 3.88%between days.Within 7 days,the inter-day RSD of dry blood spots with different dilution times(23,25,27)were 0.27%,0.65%and 0.95%,respectively.The clinical sensitivity,clinical specificity,positive predictive value and negative predictive value of dry blood spot samples in ELISA detection of syphilis antibody were 96.00%(72/75),100.00%(37/37),100.00%(72/72)and 92.50%,respectively.The results of the Kappa consistency test and Spearman rank correlation analysis showed that the Kappa value of the two methods was 0.941(P<0.01),and the correlation coefficient ρ between the S/CO ratios of the two methods was 0.211(P<0.01).The comparison of S/CO ratio results showed that the distribution characteristics of the S/CO ratio between the two methods were similar,and the ratio distribution was relatively concentrated.Conclusion:using dry blood spot samples to perform ELISA for syphilis detection has good precision,strong anti-interference ability and excellent stability.Although false-positive results appear in weak positive samples,it still has a high application value in ELISA for syphilis antibody detection,which can provide an important reference for disease diagnosis.
文献关键词:
作者姓名:
CUI Zhi-gang;DU Yan-li;JIANG Yu-shan;ZHENG Lu
作者机构:
Department of Clinical Laboratory,Harbin Blood Center,Harbin Heilongjiang 150056,China
引用格式:
[1]CUI Zhi-gang;DU Yan-li;JIANG Yu-shan;ZHENG Lu-.Enzyme-Linked Immunosorbent Assay for Detecting Syphilis Dry Blood Spot Samples)[J].中国生物医学工程学报(英文版),2022(02):64-71
A类:
B类:
Enzyme,Linked,Immunosorbent,Assay,Detecting,Syphilis,Dry,Blood,Spot,Samples,Objective,To,explore,feasibility,enzyme,linked,immunosorbent,assay,detecting,syphilis,dry,blood,spots,Methods,Based,samples,laboratory,linear,dial,basic,interference,precision,were,constructed,sensitivity,specificity,other,performances,comprehensively,evaluated,stability,was,detected,In,addition,suspected,antibody,positive,plasma,selected,control,prepared,accordingly,clinical,predictive,value,negative,detection,compared,consistency,correlation,between,two,analyzed,by,Kappa,test,rank,analysis,Results,results,showed,that,serial,dilution,ranged,from,there,good,Sensitivity,coincidence,methods,could,accurately,accuracy,RSD,different,times,batches,days,Within,respectively,coefficient,ratios,comparison,distribution,characteristics,similar,relatively,concentrated,Conclusion,using,has,strong,excellent,Although,false,appear,weak,still,high,application,which,can,provide,important,reference,disease,diagnosis
AB值:
0.333181
相似文献
Circulating Levels of Hypoxia-regulating MicroRNAs in Systemic Lupus Erythematosus Patients with Hemolytic Anemia
Amira M.Gamal-Eldeen;Cinderella A.Fahmy;Bassem M.Raafat;Fayez Althobaiti;Iman H.Bassyouni;Roba M.Talaat-Clinical Laboratory Sciences Department,College of Applied Medical Sciences,Taif University,Taif 21944,Saudi Arabia;High Altitude Research Center,Prince Sultan Medical Complex,Al-Hawiyah,Taif University,Taif 21944,Saudi Arabia;Cancer Biology and Genetics Laboratory,Centre of Excellence for Advanced Sciences,National Research Centre,Cairo 12622,Egypt;Biochemistry Department,National Research Centre,Cairo 12622,Egypt;Radiological Sciences Department,College of Applied Medical Sciences,Taif University,Taif 21944,Saudi Arabia;Biotechnology Department,Faculty of Science,Taif University,Taif 21944,Saudi Arabia;Department of Rheumatology and Rehabilitation,Faculty of Medicine,Cairo University,El-Kasr El-Aini Hospital,Cairo 12613,Egypt;Molecular Biology Department,Genetic Engineering and Biotechnology Research Institute(GEBRI),Sadat City University,Sadat City 32897,Egypt
Clinical Features and Corrected Factors with Neurosyphilis in HIV/Syphilis Co-Infected Patients Based on Stage of Syphilis
Wang Yuan-Yuan;Shi Mei;Guan Zhi-Fang;Zhang Lei;Gu Xin;Lu Hai-Kong;Qi Teng-Fei;Ni Li-Yan;Wu Juan;Zhao Wei;Peng Rui-Rui;Zhu Lin;Zhou Ping-Yu-Sexually Transmitted Disease Institute, Shanghai Skin Disease Hospital, Clinical School of Anhui Medical University, Shanghai 200050, China;Sexually Transmitted Disease Institute, Shanghai Skin Disease Hospital, Tongji University, School of Medicine, Shanghai 200050, China;China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Centre, Xi’an, Shaanxi 710049, China;Melbourne Sexual Health Centre, Alfred Health, Melbourne 3800, Australia;Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne 3800, Australia;Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, China.
Establishment and Evaluation of a Prediction Model of BLR for Severity in Coronavirus Disease 2019
He Zebao;Rui Fajuan;Yang Hongli;Ge Zhengming;Huang Rui;Ying Lingjun;Zhao Haihong;Wu Chao;Li Jie-Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang 317099, China;Department of Infectious Diseases, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang 318053, China;Department of Infectious Disease, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China;Department of Infectious Disease, Cheeloo College of Medicine, Shandong University, Ji’nan, Shandong 250012, China;Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China;Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210033, China
Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
Zhang Wenyan;Liu Wei;Lin Jiawang;Jin Jing;Zhao Kefu;Zhu Liwei;Wang Xiuzhen;Wang Lijie;Tang Renshu;Zhu Yindi;Zhou Wei;You Enqing;Zhang Lei;Liu Xuxiang;Wu Jinju;Chen Lili;Wang Wenjing;Zhang Qiang;Gao Rongbao-Hefei Center for Disease Control and Prevention, Hefei, Anhui Province 230061, China;BIOHIT Healthcare (Hefei) Co., Hefei, Anhui Province 230000, China;The First People’s Hospital of Hefei, Hefei, Anhui Province 230091, China;Anhui Provincial Hospital, Hefei, Anhui Province 231501, China;State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。